This was the stock's second consecutive day of losses.

Good morning, and welcome to the Synchrony Financial fourth quarter and full year 2024 earnings conference call. Please refer ...

Akero Therapeutics reports a 39% improvement in cirrhosis patients using EFX. See why AKRO stock is soaring with the ...

U.S. markets were rebounding at midday from yesterday's big tech selloff caused by advances in artificial intelligence by a ...

The S&P 500 and the Nasdaq were set for a slightly higher open on Tuesday, as AI-linked shares recouped some of the previous ...

In a report released yesterday, Moshe Orenbuch from TD Cowen maintained a Buy rating on Synchrony Financial (SYF – Research Report), with a ...

Synchrony Financial's fourth-quarter earnings results missed analysts' forecasts and investors pummeled the stock due to a ...

Synchrony Financial reported Q4 results with a Y/Y increase in net interest income, driven by higher interest and fees on ...

Synchrony Financial's fourth-quarter profit and revenue came up short of forecasts on higher costs and less-than-expected net interest income.

Compass Point downgraded Synchrony (SYF) to Neutral from Buy with a $70 price target Invest with Confidence: Follow TipRanks' Top Wall Street ...

BofA Securities updated its outlook on Synchrony Financial (NYSE:SYF), increasing the price target to $85.00, up from the previous $82.00, while reaffirming a Buy rating on the stock. The adjustment ...

Shares of card lender Synchrony Financial were down sharply following its earnings report on Tuesday. The company told analysts that “customers remain selective in their spending behavior.” Synchrony ...